1201 related articles for article (PubMed ID: 10388618)
1. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk.
Huber WW; Grasl-Kraupp B; Schulte-Hermann R
Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083
[TBL] [Abstract][Full Text] [Related]
3. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
Melnick RL
Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
[TBL] [Abstract][Full Text] [Related]
4. The potential health effects of phthalate esters in children's toys: a review and risk assessment.
Wilkinson CF; Lamb JC
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 1):140-55. PubMed ID: 10536109
[TBL] [Abstract][Full Text] [Related]
5. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
6. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
7. A mechanistic interpretation of the oncogenicity of chlorothalonil in rodents and an assessment of human relevance.
Wilkinson CF; Killeen JC
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):69-84. PubMed ID: 8921547
[TBL] [Abstract][Full Text] [Related]
8. The role of inhibition of gap junctional intercellular communication in rodent liver tumor induction by phthalates: review of data on selected phthalates and the potential relevance to man.
McKee RH
Regul Toxicol Pharmacol; 2000 Aug; 32(1):51-5. PubMed ID: 11029268
[TBL] [Abstract][Full Text] [Related]
9. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.
Maloney EK; Waxman DJ
Toxicol Appl Pharmacol; 1999 Dec; 161(2):209-18. PubMed ID: 10581215
[TBL] [Abstract][Full Text] [Related]
10. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
11. Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.
Ito Y; Yamanoshita O; Kurata Y; Kamijima M; Aoyama T; Nakajima T
Arch Toxicol; 2007 Mar; 81(3):219-26. PubMed ID: 16937134
[TBL] [Abstract][Full Text] [Related]
12. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
13. Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate (DEHP).
Willhite CC
Toxicology; 2001 Mar; 160(1-3):219-26. PubMed ID: 11246142
[TBL] [Abstract][Full Text] [Related]
14. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
15. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
16. Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha.
Peters JM; Taubeneck MW; Keen CL; Gonzalez FJ
Teratology; 1997 Nov; 56(5):311-6. PubMed ID: 9451755
[TBL] [Abstract][Full Text] [Related]
17. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate.
Rusyn I; Corton JC
Mutat Res; 2012; 750(2):141-158. PubMed ID: 22198209
[TBL] [Abstract][Full Text] [Related]
19. Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARĪ±) as a case study.
Corton JC; Cunningham ML; Hummer BT; Lau C; Meek B; Peters JM; Popp JA; Rhomberg L; Seed J; Klaunig JE
Crit Rev Toxicol; 2014 Jan; 44(1):1-49. PubMed ID: 24180432
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of the ability of Di(2-ethylhexyl)phthalate to induce cell transformation, chromosome aberrations, and peroxisome proliferation in cultured Syrian hamster embryo cells].
Watanabe E; Tsutsui T
Shigaku; 1989 Dec; 77(4):1371-90. PubMed ID: 2489351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
